Skip to main content
. 2019;20(1):263–267. doi: 10.31557/APJCP.2019.20.1.263

Figure 2.

Figure 2

Determination of Half-Maximal (50%) Inhibitory Concentration (IC50) of Sorafenib-Mediated Cytotoxicity in HCC Cells. Cells were cultured in the presence or absence of sorafenib for 72 h in DMEM high glucose containing 10% FBS. treatment of HepG2 cells with increasing concentrations of sorafenib (0.1-10 μmol/l; left) Data are expressed as the mean±SEM of five replicates.